Tag Archives: Novartis

NOVARTIS A.G. v. UOI – What is Novelty in Indian Courts?

Can everything old be made new again?  Lots has been written about the Indian Supreme Court rejecting a patent application claiming a crystal modification of imatinib mesylate (Gleevec), which is used to treat CML.  Novartis’ attempt to “evergreen” Gleevec with … Continue reading

Posted in Int'l Practice and Policy, Obviousness | Tagged , , , , | Leave a comment